Clinical trial
Lovastatin for the Treatment of Mildly Active Rheumatoid Arthritis
NCT00302952 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Terminated
Key facts
| NCT number | NCT00302952 |
|---|---|
| Title | Lovastatin for the Treatment of Mildly Active Rheumatoid Arthritis |
| Official title | A Double Blind, Placebo Controlled, Phase II, Randomized Study of Lovastatin Therapy in the Treatment of Mildly Active Rheumatoid Arthritis |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Collaborators | Autoimmunity Centers of Excellence |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Rheumatoid Arthritis |
| Intervention type | Drug |
| Interventions | Lovastatin, Placebo |
| Enrollment | 64 |
| Start date | Nov 6, 2007 |
| Primary completion | Apr 30, 2012 |
| Completion | Apr 30, 2012 |
| First posted | Mar 15, 2006 |
| Last update posted | Sep 7, 2022 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: